ProgramsView all programs
From the news
- Chancellor Amma Addresses the Parliament of World’s Religions
- Amrita Students Qualify for the European Mars Rover Challenge
Publication Type : Journal Article
Thematic Areas : Medical Sciences
Publisher : Indian Journal of Gynecologic Oncology.
Source : Indian Journal of Gynecologic Oncology, Volume 14, Number 4, p.60 (2016)
Campus : Kochi
School : School of Medicine
Department : Medical Oncology
Year : 2016
Abstract : Locally advanced breast cancer (LABC) is best managed by neoadjuvant chemotherapy followed by surgery and radiotherapy. Recent reports suggest that complete pathological response is associated with improved survival. Major concern of using concurrent chemoradiation in LABC is toxicity and cosmesis, and only very few studies addressed this issue. This study is carried out to study the feasibility, toxicity profile, pathological response of neoadjuvant anthracycline-based chemotherapy followed by concurrent chemoradiation with biweekly paclitaxel in locally advanced breast cancer patients.
Cite this Research Publication : Beena Kunheri, Kottarathil, V. Dehannathp, Makuny, D., Keechilat, P., and Padmanabhan, T. K., “Neoadjuvant Chemotherapy Followed by Neoadjuvant Concurrent Chemoradiation for Locally Advanced Breast Cancer: a Feasibility Study and 10-year Follow-up Results”, Indian Journal of Gynecologic Oncology, vol. 14, p. 60, 2016.